Concord Medical Group PRIME — New York, New York

Concord Medical Group PRIME is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Concord Medical Group PRIME has participated in 2 clinical trials.

Therapeutic areas: Crohn Disease, Ulcerative Colitis.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Concord Medical Group PRIME?

Concord Medical Group PRIME has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Concord Medical Group PRIME conducted?

Concord Medical Group PRIME has 2 clinical trials on record. Their work covers Crohn Disease, Ulcerative Colitis.

Is Concord Medical Group PRIME accredited by Crixeo Health?

Concord Medical Group PRIME has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Concord Medical Group PRIME?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.